In-Office Laryngeal Laser Treatment

Maiman TH. Stimulated optical radiation in ruby. Nature. 1960;187(4736):493–4. Yan Y, et al. Use of lasers in laryngeal surgery. J Voice. 2010;24(1):102–9. Rees CJ, Postma GN, Koufman JA. Cost savings of unsedated office-based laser surgery for laryngeal papillomas. Ann Otol Rhinol Laryngol. 2007;116(1):45–8. Rees CJ, et al. Patient tolerance of in-office pulsed dye laser treatments to the upper aerodigestive tract. Otolaryngol Head Neck Surg. 2006;134(6):1023–7. Rosen CA, et al. Advances in office-based diagnosis and treatment in laryngology. Laryngoscope. 2009;119(Suppl 2):S185–212. Koufman JA. Introduction to office-based surgery in laryngology. Curr Opin Otolaryngol Head Neck Surg. 2007;15(6):383–6. Wang SX, Simpson CB. Anesthesia for office procedures. Otolaryngol Clin North Am. 2013;46(1):13–9. Franco RA Jr. In-office laryngeal surgery with the 585-nm pulsed dye laser. Curr Opin Otolaryngol Head Neck Surg. 2007;15(6):387–93. Morrison MP, et al. Hemodynamic changes during otolaryngological office-based flexible endoscopic procedures. Ann Otol Rhinol Laryngol. 2012;121(11):714–8. Fritz MA, et al. The safety of antithrombotic therapy during in-office laryngeal procedures—a preliminary study. J Voice; 2015. doi: 10.1016/j.jvoice.2014.12.007 McMillan K, et al. A 585-nm pulsed dye laser treatment of laryngeal papillomas: preliminary report. Laryngoscope. 1998;108(7):968–72. Bower CM, et al. Flash pump dye laser treatment of laryngeal papillomas. Ann Otol Rhinol Laryngol. 1998;107(12):1001–5. •• Koufman JA, et al. Office-based laryngeal laser surgery: a review of 443 cases using three wavelengths. Otolaryngol Head Neck Surg. 2007; 137(1): 146–51. Review of 443 cases proving the safety and efficacy of in-office, awake laryngeal laser while also providing comparison for PDL, CO 2 and thulium lasers. Zeitels SM, et al. Office-based treatment of glottal dysplasia and papillomatosis with the 585-nm pulsed dye laser and local anesthesia. Ann Otol Rhinol Laryngol. 2004;113(4):265–76. Ayala C, et al. Ultrastructural evaluation of 585-nm pulsed-dye laser-treated glottal dysplasia. J Voice. 2007;21(1):119–26. Franco RA Jr. Aminolevulinic acid 585 nm pulsed dye laser photodynamic treatment of laryngeal keratosis with atypia. Otolaryngol Head Neck Surg. 2007;136(6):882–7. Sheu M, et al. Multi-institutional experience with the in-office potassium titanyl phosphate laser for laryngeal lesions. J Voice. 2012;26(6):806–10. Mallur PS, et al. A model for 532-nm pulsed potassium titanyl phosphate (KTP) laser-induced injury in the rat larynx. Laryngoscope. 2009;119(10):2008–13. Sridharan S, et al. Patient-based outcomes of in-office KTP ablation of vocal fold polyps. Laryngoscope. 2014;124(5):1176–9. Xie X, et al. KTP 532 nm laser for laryngeal lesions. A systematic review. J Voice. 2013;27(2):245–9. • Pitman MJ, et al. Effect of the 532 nm pulsed KTP laser in the treatment of Reinke’s edema. The Laryngoscope. 2012; 122(12): 2786–92. Retrospective that proved the safety of bilateral treatment of Reinke’s and proved the histologic preservation of the vocal fold vibratory epithelium and persistence of the mucosal wave. • Zeitels SM, et al. Local injection of bevacizumab (Avastin) and angiolytic KTP laser treatment of recurrent respiratory papillomatosis of the vocal folds: a prospective study. Ann Otol Rhinol Laryngol. 2011; 120(10): 627–34. Prospective study showing efficacy of combining avastin injection and KTP ablation for poorly controlled RRP. Mallur PS, et al. Proposed classification system for reporting 532-nm pulsed potassium titanyl phosphate laser treatment effects on vocal fold lesions. The Laryngoscope. 2014;124(5):1170–5. Wang Z, et al. Fiber-guided CO2 laser surgery in an animal model. Photomed Laser Surg. 2006;24(5):646–50. Halum SL, Moberly AC. Patient tolerance of the flexible CO2 laser for office-based laryngeal surgery. J Voice. 2010;24(6):750–4. Zeitels SM, et al. Office-based and microlaryngeal applications of a fiber-based thulium laser. Ann Otol Rhinol Laryngol. 2006;115(12):891–6. Ivey CM, et al. Office pulsed dye laser treatment for benign laryngeal vascular polyps: a preliminary study. Ann Otol Rhinol Laryngol. 2008;117(5):353–8. Sung CK. Office-based laser laryngeal surgery. Oper Tech Otolaryngol-Head Neck Surg. 2012;23(2):102–5. •• Burns JA, et al. Predicting clinical efficacy of photoangiolytic and cutting/ablating lasers using the chick chorioallantoic membrane model: implications for endoscopic voice surgery. The Laryngoscope. 2008; 118(6): 1109–124. Directly compared KTP, PDL, CO 2 and thulium lasers on a chick chorioallantoic membrane model which showed that smaller vessels coagulate at pulse widths <15 ms and larger vessels require pulse widths of >35 ms. Wang CT, et al. Comparison of treatment outcomes of transnasal vocal fold polypectomy versus microlaryngoscopic surgery. The Laryngoscope. 2015;125(5):1155–60. Kuo CY, Halum SL. Office-based laser surgery of the larynx: cost-effective treatment at the office’s expense. Otolaryngol Head Neck Surg. 2012;146(5):769–73. Tanzi EL, Lupton JR, Alster TS. Lasers in dermatology: four decades of progress. J Am Acad Dermatol. 2003;49(1):1–34. Mortensen MM, et al. The use of the pulse dye laser in the treatment of vocal fold scar: a preliminary study. The Laryngoscope. 2008;118(10):1884–8. • Shakeri-Zadeh A, et al. A scientific paradigm for targeted nanophotothermolysis; the potential for nanosurgery of cancer. Lasers Med Sci. 2014; 29(2): 847–53. Describes the use of gold nanoparticles to target cancer cells and the use of optical fibers to transfer the visible or near-infrared light to the source. Li JL, et al. In vitro cancer cell imaging and therapy using transferrin-conjugated gold nanoparticles. Cancer Lett. 2009;274(2):319–26.